FindTrial
Sign In

The role of speckle-tracking echocardiography in evaluating cardiac function with Beta blocker in the treatment of septic cardiomyopathy

The role of speckle-tracking echocardiography in evaluating cardiac function with Beta blocker in the treatment of septic cardiomyopathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100047513
Enrollment
Unknown
Registered
2021-06-20
Start date
2021-06-20
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sepsis induced cardiomyopathy

Interventions

Group A:Conventional treatment combined with beta blocker
Group B:Conventional treatment

Sponsors

Tianjin Third Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients with sepsis/septic shock as defined in the SEPSIS-3 guidelines in 2016; 2. Diagnosis of sepsis/septic shock within 24 hours of admission; 3. Aged over 18 years.

Exclusion criteria

Exclusion criteria: 1. Any history of ischemic heart disease at any time in the past; 2. Previous history of chronic heart failure, moderate/severe valvular heart disease, primary pulmonary hypertension, pulmonary heart disease, uremia, long-term dialysis, and asthma; 3. Previous valve replacement, coronary artery bypass, coronary artery stent implantation, and thoracic surgery; 4. Transmitted patients diagnosed with sepsis before admission and treated in another hospital for more than 48 hours; 5. Poor image quality of echocardiography; 6. Patients or their relatives refuse to sign the informed consent form.

Design outcomes

Primary

MeasureTime frame
TnI;—

Countries

Chnia

Contacts

Public ContactXu Lei

Tianjin Third Central Hospital

nokia007008@163.com+86 13032288771

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026